Literature DB >> 21611876

Role of thrombolestagrophy in monitoring perioperative coagulation status and effect of thromboprophylaxis in bariatric surgery.

Francesco Forfori1, Baldassare Ferro, Biancamaria Mancini, Ricci Letizia, Antonio Abramo, Marco Anselmino, Claudio Di Salvo, Francesco Giunta.   

Abstract

BACKGROUND: Thromboelastography is a technique that surveys the properties of viscoelastic blood clot. The purpose of this paper was to evaluate the hypercoagulability state and the effect of antithrombotic prophylaxis on thromboelastogram (TEG) results in bariatric surgery.
METHODS: Twenty-five patients enrolled received 0.8 ml of nodraparin starting on the day before surgery and continuing postoperatively. TEG profile was collected before induction of anesthesia, on the first and third postoperative days. Each sample was run also in a cup added with heparinase to eliminate the interference of antithrombotic prophylaxis.
RESULTS: TEG analysis with heparinase showed a tendency to reduce the r-time (rate of initial fibrin formation) and k-time (time to clot firmness) and increase the alpha angle (rate of clot growth), while an increase of maximal amplitude (MA, a measure of maximal stiffness of the clot; p = 0.01) and GI or shear elastic modules strength (p = 0.03)was observed from basal to postoperative day 3 (POD3). TEG without heparinase evidenced and increase of r-time (p = 0.02) and k-time (p = 0.05), a reduction of the alpha angle (p = 0.03), and an increase of MA (p = 0.01) and GI (p = 0.03) from basal to POD3. The comparison of TEG techniques showed that normal TEGs had lower values of r-time and k-time and higher values of alpha angles and MA than TEG with heparinase. No differences were evident for basal and POD1 samples and the G values comparing the two TEG technique. No correlation was observed between the variation of normal TEG parameters and dosage of anticoagulant used in each patient.
CONCLUSIONS: Our patients presented a tendency to hypercoagulability determined most by MA and GI. Comparison between TEGs indicates that low-molecular-weight heparin not titrated on weight is able to determine a reduction of hypercoabulable tendency in the early postoperative period with few effects on increasing MA and GI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21611876     DOI: 10.1007/s11695-011-0443-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  15 in total

1.  Prophylaxis of Venous Thromboembolism in Bariatric Patients.

Authors: 
Journal:  Obes Surg       Date:  2000-02       Impact factor: 4.129

2.  Can Thromboelastography performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters?

Authors:  H White; C Zollinger; M Jones; R Bird
Journal:  Int J Lab Hematol       Date:  2009-03-17       Impact factor: 2.877

Review 3.  Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery.

Authors:  Ana T Rocha; Angela G de Vasconcellos; Epitácio R da Luz Neto; Danilo M A Araújo; Erivaldo S Alves; Antônio Alberto Lopes
Journal:  Obes Surg       Date:  2006-12       Impact factor: 4.129

4.  Platelet function tests in pre- and post-operative patients with and without thrombosis.

Authors:  J R O'Brien; V Tulevski; M Etherington
Journal:  Acta Univ Carol Med Monogr       Date:  1972

5.  Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery.

Authors:  E Mahla; T Lang; M N Vicenzi; G Werkgartner; R Maier; C Probst; H Metzler
Journal:  Anesth Analg       Date:  2001-03       Impact factor: 5.108

6.  Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.

Authors:  Matthew T Rondina; Michelle Wheeler; George M Rodgers; Leslie Draper; Robert C Pendleton
Journal:  Thromb Res       Date:  2009-03-09       Impact factor: 3.944

7.  Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis.

Authors:  James A Sapala; Michael H Wood; Michael P Schuhknecht; M Andrew Sapala
Journal:  Obes Surg       Date:  2003-12       Impact factor: 4.129

Review 8.  Obesity and thromboembolic disease.

Authors:  Paul D Stein; Jose Goldman
Journal:  Clin Chest Med       Date:  2009-09       Impact factor: 2.878

9.  Prevalence of thrombophilias in patients presenting for bariatric surgery.

Authors:  D Wayne Overby; Geoffrey P Kohn; Mitchell A Cahan; Joseph A Galanko; Karen Colton; Stephan Moll; Timothy M Farrell
Journal:  Obes Surg       Date:  2009-07-05       Impact factor: 4.129

Review 10.  Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature.

Authors:  Yue Dai; Anna Lee; Lester A H Critchley; Paul F White
Journal:  Anesth Analg       Date:  2009-03       Impact factor: 5.108

View more
  6 in total

1.  Prospective assessment of fibrinolysis in morbid obesity: tissue plasminogen activator resistance improves after bariatric surgery.

Authors:  Jason Samuels; Peter J Lawson; Alexander P Morton; Hunter B Moore; Kirk C Hansen; Angela Sauaia; Jonathan A Schoen
Journal:  Surg Obes Relat Dis       Date:  2019-04-10       Impact factor: 4.734

2.  Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

Authors:  Farraj Moaad; Bramnik Zakhar; Kvasha Anton; Merie Moner; Sbeit Wisam; Farraj Safy; Waksman Igor
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

3.  Low molecular weight heparin once versus twice for thromboprophylaxis following esophagectomy: a randomised, double-blind and placebo-controlled trial.

Authors:  Jie-Qiong Song; Li-Zhen Xuan; Wei Wu; Jun-Feng Huang; Ming Zhong
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

4.  Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery.

Authors:  Pilar Taura; Eva Rivas; Graciela Martinez-Palli; Annabel Blasi; Juan Carlos Holguera; Jaume Balust; Salvadora Delgado; Antonio M Lacy
Journal:  Surg Endosc       Date:  2013-09-17       Impact factor: 4.584

5.  Monitoring of Hypercoagulability by Thromboelastography in Bariatric Surgery.

Authors:  Kristina Kupcinskiene; Darius Trepenaitis; Ruta Petereit; Juozas Kupcinskas; Rita Gudaityte; Almantas Maleckas; Andrius Macas
Journal:  Med Sci Monit       Date:  2017-04-15

6.  Thromboelastographic changes during laparoscopic fundoplication.

Authors:  Indre Zostautiene; Kristina Zvinienė; Darius Trepenaitis; Rolandas Gerbutavičius; Antanas Mickevičius; Rima Gerbutavičienė; Mindaugas Kiudelis
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-03-13       Impact factor: 1.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.